Hsa-miR-6812: A Potential Drug Target and Biomarker for Cancer

Hsa-miR-6812: A Potential Drug Target and Biomarker for Cancer

MIR6812 (hsa-miR-6812-3p) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression patterns have made it an attractive target for researchers to study and develop new treatments.

MIR6812 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. It is expressed in a variety of tissues and cells and can interact with other molecules to regulate gene expression. The miRNA pathway is a well-established mechanism for regulating gene expression and has been implicated in various diseases, including cancer.

The hsa-miR-6812 gene is located on chromosome 6 and encodes a 21- amino acid RNA molecule. It is expressed in various tissues, including brain, heart, and muscle, and has been shown to play a role in regulating gene expression. Studies have shown that hsa-miR-6812 is highly expressed in cancer tissues and is associated with poor prognosis in cancer patients.

One of the key features of hsa-miR-6812 is its expression pattern. It is primarily expressed in the cytoplasm of cancer cells and has a limited expression in the nucleus. This is consistent with the idea that it is involved in the regulation of gene expression in the cytoplasm, rather than the nucleus.

Another feature of hsa-miR-6812 is its length. It has a length of 20 amino acids, which is unusual for a miRNA. This length may be important for its function, as it allows it to interact with other molecules in the cell.

The structure of hsa-miR-6812 has also been studied to determine its potential as a drug target. It has a conserved binding site in the middle of the molecule, which suggests that it may interact with other molecules in the cell. Studies have shown that hsa-miR-6812 can interact with the protein encoded by the gene KLF1. This suggests that hsa-miR-6812 may be a negative regulator of KLF1, which could be a potential drug target.

In addition to its potential as a drug target, hsa-miR-6812 has also been identified as a potential biomarker for cancer. Its expression patterns have been shown to be altered in various types of cancer, including breast, lung, and ovarian cancer. This suggests that hsa-miR-6812 may be a useful biomarker for cancer diagnosis and treatment.

Overall, hsa-miR-6812 is a promising drug target and biomarker for various diseases. Its unique structure and expression patterns make it an attractive target for researchers to study and develop new treatments. Further research is needed to fully understand its role in the regulation of gene expression and its potential as a drug and biomarker.

Protein Name: MicroRNA 6812

The "MIR6812 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR6812 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR6813 | MIR6814 | MIR6815 | MIR6816 | MIR6817 | MIR6818 | MIR6819 | MIR6820 | MIR6821 | MIR6822 | MIR6823 | MIR6824 | MIR6825 | MIR6826 | MIR6827 | MIR6828 | MIR6829 | MIR6830 | MIR6831 | MIR6832 | MIR6833 | MIR6834 | MIR6836 | MIR6837 | MIR6839 | MIR6840 | MIR6841 | MIR6842 | MIR6843 | MIR6844 | MIR6845 | MIR6846 | MIR6847 | MIR6848 | MIR6849 | MIR6850 | MIR6851 | MIR6852 | MIR6853 | MIR6854 | MIR6855 | MIR6856 | MIR6857 | MIR6858 | MIR6859-1 | MIR6859-2 | MIR6859-3 | MIR6859-4 | MIR6860 | MIR6861 | MIR6862-1 | MIR6862-2 | MIR6863 | MIR6864 | MIR6865 | MIR6866 | MIR6867 | MIR6868 | MIR6869 | MIR6870 | MIR6871 | MIR6872 | MIR6873 | MIR6874 | MIR6875 | MIR6876 | MIR6877 | MIR6878 | MIR6879 | MIR6880 | MIR6881 | MIR6882 | MIR6883 | MIR6884 | MIR6885 | MIR6886 | MIR6887 | MIR6888 | MIR6889 | MIR6890 | MIR6891 | MIR6892 | MIR6893 | MIR6894 | MIR6895 | MIR7-1 | MIR7-2 | MIR7-3 | MIR7-3HG | MIR708 | MIR7106 | MIR7107 | MIR7108 | MIR7109 | MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114